British Journal of Haematology · 2020 · 23 citations · 6 references
Life SciencesHematologyImmunologyCancer ImmunologyClinical ImmunologyImmunopathologyB Cell ActivationB Cell BiologyB Cell DevelopmentDiagnostic ImmunologyImmuno-oncology BiomarkersMultiple MyelomaB-cell BiomarkersPeripheral Blood Immune BiomarkersReference Interval DeterminationReference Interval EstablishmentReference Range DeterminationReference Range DevelopmentReference Range Establishment
The serum B-cell maturation antigen (sBCMA) has been identified as a novel serum biomarker for patients with multiple myeloma. However, no study has yet established a reference range for sBCMA levels. Its levels were determined in 196 healthy subjects and showed a right-tailed distribution with a median value of 37·51 ng/ml with a standard deviation of 22·54 ng/ml (range 18·78-180·39 ng/ml). Partitioning of subgroup reference ranges was considered but determined to be irrelevant. A non-parametric method using the median ± 2 standard deviations suggests using a universal reference interval of <82·59 ng/ml.
6
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2019 · 21K citations · Full text
γ-secretase directly sheds the survival receptor BCMA from plasma cells
Sarah Laurent, Franziska Hoffmann, Peer‐Hendrik Kuhn et al. · Nature Communications · 2015 · 364 citations · Full text